Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01688700
https://clinicaltrials.gov/show/NCT01688700
December 16, 2019
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
In order to download data models you must be logged in. Please log in or register for free.
Please use this form for feedback, questions and suggestions for improvements.